Literature DB >> 10781624

Evaluation of abnormal liver-enzyme results in asymptomatic patients.

D S Pratt1, M M Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10781624     DOI： 10.1056/NEJM200004273421707

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  263 in total

1.  Alanine aminotransferase regulation by androgens in non-hepatic tissues.

Authors:  Christopher C Coss; Matt Bauler; Ramesh Narayanan; Duane D Miller; James T Dalton
Journal:  Pharm Res       Date:  2011-12-14       Impact factor: 4.200

2.  [Monitoring of hypertransaminasaemia in primary care clinics].

Authors:  A Ortega Carpio; M Mora García; P Batalha Caetano; R Fernández Leal
Journal:  Aten Primaria       Date:  2003-10-15       Impact factor: 1.137

3.  To perform or not to perform liver biopsy-that is the question.

Authors:  R W Chapman
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

4.  Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program.

Authors:  Cary H Patt; Hwan Y Yoo; Kourosh Dibadj; John Flynn; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 5.  Alcoholic foamy degeneration and a markedly elevated GGT: a case report and literature review.

Authors:  Sanjeev Suri; Frank A Mitros; Jatinder P Ahluwalia
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

Review 6.  Evaluation of abnormal liver function tests.

Authors:  J K Limdi; G M Hyde
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401

7.  Liver function tests: defining what's normal.

Authors:  Paul Roderick
Journal:  BMJ       Date:  2004-04-24

8.  Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Mitsuhito Koizumi; Shinya Furukawa; Teruhisa Ueda; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-02-14       Impact factor: 7.527

Review 9.  Clinical approaches to non-alcoholic fatty liver disease.

Authors:  Katherine J P Schwenger; Johane P Allard
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.

Authors:  Pedro Zapater; José Such; Miguel Pérez-Mateo; José Francisco Horga
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.